Skip to main content
. 2022 May 23;21:e20210198. doi: 10.1590/1677-5449.202101981

Table 1. Study to define the best cutoff point for the screening questionnaire.

Cutoff point Probability of diagnosis of lipedema 95% confidence interval Sensitivity Specificity Prevalence in the study population
5 21.9% 12.7-35.2% 1 0.593 51.0% (129)
6 28.7% 18.4-41.8% 0.94 0.644 42.3% (107)
7 36.6% 25.5-49.4% 0.9 0.695 37.2% (94)
8 45.3% 33.6-57.6% 0.88 0.729 30.4% (77)
9 54.3% 42.0-66.1% 0.78 0.780 24.9% (63)
10 63.0% 50.1-74.3% 0.66 0.831 19.4% (49)
11 71.0% 57.5-81.5% 0.58 0.831 15.0% (38)
12 77.8% 64.2-87.3% 0.46 0.880 12.3% (31)
13 83.4% 70.1-91.5% 0.38 0.949 7.9% (20)
14 87.8% 75.2-94.5% 0.26 0.966 4.7% (12)
15 91.2% 79.6-96.5% 0.18 0.966 4.7% (12)
16 93.7% 83.3-97.8% 0.06 0.983 3.2% (8)
17 95.5% 86.4-98.6% 0.04 1.000 2.4% (6)